474
Views
2
CrossRef citations to date
0
Altmetric
Articles

COPD in the major nonsmoking adult: A systematic review and meta-analysis

& ORCID Icon

References

  • Almagro P, Salvadó M, Garcia-Vidal C, et al. Recent improvement in long-term survival after a COPD hospitalisation. Thorax. 2010;65(4):298–302. doi:10.1136/thx.2009.124818.
  • GOLD. Global strategy for Diagnosis, Management, and Prevention of COPD, Global Initiative for Chronic Obstructive Lung Disease (GOLD). 2015. http://www.goldcopd.org/.
  • Agusti A, Bartolome CR. Gold Reports 2018. 2018. https://goldcopd.org/gold-reports/.
  • Gershon AS, Dolmage TE, Stephenson A, Jackson B. Chronic obstructive pulmonary disease and socioeconomic status: a systematic review. COPD. 2012;9(3):216–226. doi:10.3109/15412555.2011.648030.
  • Barreiro E, Criner GJ. Update in chronic obstructive pulmonary disease 2013. Am J Respir Crit Care Med. 2014;189(11):1337–1344. doi:10.1164/rccm.201402-0245UP.
  • Zhang J, Lin XF, Bai CX. Comparison of clinical features between non-smokers with COPD and smokers with COPD: a retrospective observational study. Int J Chron Obstruct Pulmon Dis. 2014;9:57–63. doi:10.2147/COPD.S52416.
  • Asociación Latinoamericana de Tórax. Recomendaciones para el diagnóstico y tratamiento de la enfermedad pulmonar obstructiva crónica (EPOC). 2011. http://www.alatorax.org/index.php?option=com_content&view=category&layout=blog&id=163&Itemid=213&lang=es.
  • Ansari AM, Dixit S. Epidemiology of chronic obstructive pulmonary disease among smokers and nonsmokers: a clinical study. J Adv Med Dent Sci Res. 2016;4(6):100–102. doi:10.21276/jamdsr.2016.4.6.22.
  • Estrada HG. EPOC. Diagnóstico y Tratamiento Integral. 4.a edición. Colombia: Editorial Médica Panamericana; 2020.
  • INEC. Anuario de Estadísticas Hospitalarias: Egresos y Camas 2013. 2013. http://www.ecuadorencifras.gob.ec/documentos/web-inec/Estadisticas_Sociales/Camas_Egresos_Hospitalarios/Publicaciones-Cam_Egre_Host/Anuario_Camas_Egresos_Hospitalarios_2013.pdf.
  • Menezes A. Proyecto Latinoamericano de investigacion en obstrucción Pulmonar. PLATINO. Asociación Latinoamericana del Tórax (ALAT); 2006.
  • Perez-Padilla R, Fernandez R, Lopez Varela MV, et al. Airflow obstruction in never smokers in five Latin American cities: The PLATINO Study. Arch Med Res. 2012;43(2):159–165. doi:10.1016/j.arcmed.2012.03.007.
  • Lam KBH, Yin P, Jiang CQ, et al. Past dust and GAS/FUME exposure and COPD in Chinese: the Guangzhou Biobank Cohort Study. Respir Med. 2012;106(10):1421–1428. doi:10.1016/j.rmed.2012.05.009.
  • Mehta AJ, Miedinger D, Keidel D, et al. Occupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss cohort study on air pollution and lung and heart diseases in adults. Am J Respir Crit Care Med. 2012;185(12):1292–1300. doi:10.1164/rccm.201110-1917OC.
  • Rodríguez E, Ferrer J, Zock JP, PAC-COPD Study Group, et al. Lifetime occupational exposure to dusts, gases and fumes is associated with bronchitis symptoms and higher diffusion capacity in COPD patients. PLoS One. 2014;9(2):e88426doi:10.1371/journal.pone.0088426.
  • Tommola M, Ilmarinen P, Tuomisto LE, Lehtimäki L, Kankaanranta H. Occupational exposures and asthma-COPD overlap in a clinical cohort of adult-onset asthma. ERJ Open Res. 2019;5(4):00191–2019. doi:10.1183/23120541.00191-2019.
  • Pena X, Van Den Eynde E, Mene E, Recio J. EPOC y enfermedad cardiovascular. Rev Clin Esp. 2007;207(1):14–21.
  • Banerjee A, Mondal NK, Das D, Ray MR. Neutrophilic inflammatory response and oxidative stress in premenopausal women chronically exposed to indoor air pollution from biomass burning. Inflammation. 2012;35(2):671–683. doi:10.1007/s10753-011-9360-2.
  • Mukherjee B, Dutta A, Roychoudhury S, Ray MR. Chronic inhalation of biomass smoke is associated with DNA damage in airway cells: Involvement of particulate pollutants and benzene. J Appl Toxicol. 2013;33(4):281–289. doi:10.1002/jat.1748.
  • United Nations. Centro de Información de la ONU. Día Mundial de la Enfermedad Pulmonar Obstructiva Crónica (EPOC). 2008. http://www.cinu.mx/eventos/observancia/dia-mundial-de-la-enfermedad-p-2/.
  • Salvi SS, Manap R, Beasley R. Understanding the true burden of COPD: the epidemiological challenges. Prim Care Respir J. 2012;21(3):249–251. doi:10.4104/pcrj.2012.00082.
  • Mahmood T, Singh RK, Kant S, Shukla AD, Chandra A, Srivastava RK. Prevalence and etiological profile of chronic obstructive pulmonary disease in nonsmokers. Lung India. 2017;34(2):122–126. doi:10.4103/0970-2113.201298.
  • Srivastava A, Srivastaba M. Assessment of risk factors associated with chronic obstructive pulmonary disease: A clinical study. J Adv Med Dent Sci Res. 2017;5(1):138–141. doi:10.21276/jamdsr.2017.5.1.31.
  • Hagstad S, Backman H, Bjerg A, et al. Prevalence and risk factors of COPD among never-smokers in two areas of Sweden-Occupational exposure to gas, dust or fumes in an important risk factor. Respir Med. 2015;109(11):1439–1445. doi:10.1016/j.rmed.2015.09.012.
  • Tan WC, Sin DD, Bourbeau J, CanCOLD Collaborative Research Group, et al. Characteristics of COPD in never-smokers and ever smokers in the general population: Results from the CanCOLD Study. Thorax. 2015;70(9):822–829. doi:10.1136/thoraxjnl-2015-206938.
  • Ramadan MB, Elmahallawy II. Prevalence characteristics of COPD in never smokers. Egypt J Chest Dis Tuberc. 2012;61(3):59–65. doi:10.1016/j.ejcdt.2012.10.035.
  • Hagstad S, Ekerljung L, Lindberg A, Backman H, Rönmark E, Lundbäck B. COPD among non-smokers - report from the obstructive lung disease in Northern Sweden (OLIN) studies . Respir Med. 2012;106(7):980–988. doi:10.1016/j.rmed.2012.03.010.
  • Barnes PJ, Celli BR. Systemic Manifestations and Comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. doi:10.1183/09031936.00128008.
  • Lee SJ, Kim SW, Kong KA, Ryu YJ, Lee JH, Chang JH. Risk factors for chronic obstructive pulmonary disease among never-smokers in Korea. Int J Chron Obstruct Pulmon Dis. 2015;10:497–506. doi: 10.2147/COPD.S77662 PMID: 25784796.
  • Denguezli M, Daldoul H, Harrabi I, et al. COPD in nonsmokers: Reports from the tunisian population-based burden of obstructive lung disease study. PLoS One. 2016;11(3):e0151981e0151981. doi:10.1371/journal.pone.0151981.
  • Zhou Y, Wang C, Yao W, et al. COPD in Chinese Nonsmokers. Eur Respir J. 2009;33(3):509–518. doi:10.1183/09031936.00084408.
  • Aryal S, Diaz-Guzman E, Mannino DM. Influence of sex on chronic obstructive pulmonary disease risk and treatment outcomes. Int J Chron Obstruct Pulmon Dis. 2014;9:1145–1154. doi:10.2147/COPD.S54476.
  • Arancibia F. Enfermedad Pulmonar Obstructiva Crónica y Tabaquismo. Rev Chil Enferm Respir. 2017;33(3):225–229. doi: 10.4067/s0717-73482017000300225.
  • Salvi SS, Barnes PJ. Chronic Obstructive Pulmonary Disease in Non-Smokers. Lancet. 2009;374(9691):733–743. doi:10.1016/S0140-6736(09)61303-9.
  • Yin P, Jiang CQ, Cheng KK, et al. Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study. Lancet. 2007;370(9589):751–757. doi:10.1016/S0140-6736(07)61378-6.
  • González FJ, Takkouche B, Valdés L, et al. Tabaquismo parental y función pulmonar en niños y adolescentes sanos. Arch Bronconeumol. 2007;43(2):81–85. doi:10.1157/13098418.
  • Andersen ZJ, Hvidberg M, Jensen SS, et al. Chronic obstructive pulmonary disease and long-term exposure to traffic-related air pollution: A cohort study. Am J Respir Crit Care Med. 2011;183(4):455–461. doi:10.1164/rccm.201006-0937OC.
  • Gan WQ, FitzGerald JM, Carlsten C, Sadatsafavi M, Brauer M. Associations of Ambient Air Pollution With Chronic Obstructive Pulmonary Disease Hospitalization and Mortality. Am J Respir Crit Care Med. 2013;187(7):721–727. doi:10.1164/rccm.201211-2004OC.
  • Caillaud D, Lemoigne F, Carré P, et al. Association between occupational exposure and the clinical characteristics of COPD. BMC Public Health. 2012;12(1):302. doi:10.1186/1471-2458-12-302.
  • Alvarado A. Chronic obstructive pulmonary disease in non-smokers: An Update. Clin Res Trial. 2018;4(2):1–8. doi:10.15761/CRT.1000216.
  • Postma DS, Bush A, van den Berge M. Risk Factors and Early Origins of Chronic Obstructive Pulmonary Disease. Lancet. 2015;385(9971):899–909. doi:10.1016/S0140-6736(14)60446-3.
  • Penña VS, Miravitlles M, Gabriel R, et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest. 2000;118(4):981–989. doi:10.1378/chest.118.4.981.
  • World Healh Organization (WHO). Chronic obstructive pulmonary disease (COPD). 2017. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd).
  • Gea-Izquierdo E, Epidemiología Pd. Quito: Pontificia Universidad Católica del Ecuador/Hojas y Signos; 2019.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.